Both in Biotechnology
eXoZymes vs Pelthos Therapeutics
Over the past year EXOZ returned −70.6% and PTHS returned −73.0%; their daily moves had a correlation of 0.11.
EXOZ −70.6% PTHS −73.0%Growth of $1, one year, split-adjusted
| Metric | EXOZ | PTHS |
|---|---|---|
| Price | $4.11 | $9.30 |
| Market cap | $38.2M | $36.6M |
| Today | −4.64% | −8.37% |
| 1 month | −25.8% | −55.7% |
| 6 months | −58.9% | −62.8% |
| Year to date | −62.3% | −70.0% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 76.9% |
| Net margin | — | −150.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.8× |
| Net cash | $5.6M | -$45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 74.7% | 141.3% |
| Short % of float | 0.7% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).